• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两样本孟德尔随机化分析使用疾病进展多层次模型的结果。

Two sample Mendelian Randomisation using an outcome from a multilevel model of disease progression.

机构信息

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.

出版信息

Eur J Epidemiol. 2024 May;39(5):521-533. doi: 10.1007/s10654-023-01093-2. Epub 2024 Jan 28.

DOI:10.1007/s10654-023-01093-2
PMID:38281297
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11219432/
Abstract

Identifying factors that are causes of disease progression, especially in neurodegenerative diseases, is of considerable interest. Disease progression can be described as a trajectory of outcome over time-for example, a linear trajectory having both an intercept (severity at time zero) and a slope (rate of change). A technique for identifying causal relationships between one exposure and one outcome in observational data whilst avoiding bias due to confounding is two sample Mendelian Randomisation (2SMR). We consider a multivariate approach to 2SMR using a multilevel model for disease progression to estimate the causal effect an exposure has on the intercept and slope. We carry out a simulation study comparing a naïve univariate 2SMR approach to a multivariate 2SMR approach with one exposure that effects both the intercept and slope of an outcome that changes linearly with time since diagnosis. The simulation study results, across six different scenarios, for both approaches were similar with no evidence against a non-zero bias and appropriate coverage of the 95% confidence intervals (for intercept 93.4-96.2% and the slope 94.5-96.0%). The multivariate approach gives a better joint coverage of both the intercept and slope effects. We also apply our method to two Parkinson's cohorts to examine the effect body mass index has on disease progression. There was no strong evidence that BMI affects disease progression, however the confidence intervals for both intercept and slope were wide.

摘要

确定导致疾病进展的因素,特别是在神经退行性疾病中,是非常重要的。疾病进展可以描述为随着时间的推移,结局的轨迹,例如,线性轨迹既有截距(零时的严重程度)又有斜率(变化率)。在观察性数据中,有一种用于识别一个暴露因素与一个结局之间因果关系的技术,即两样本 Mendelian Randomisation(2SMR),同时避免由于混杂导致的偏倚。我们考虑了一种使用疾病进展多层次模型的多变量 2SMR 方法,以估计暴露因素对截距和斜率的因果效应。我们进行了一项模拟研究,比较了一种简单的单变量 2SMR 方法和一种多变量 2SMR 方法,后者有一个暴露因素,影响随时间变化的线性结局的截距和斜率。在六个不同的场景中,两种方法的模拟研究结果相似,没有证据表明存在非零偏差和适当覆盖 95%置信区间(对于截距为 93.4-96.2%,斜率为 94.5-96.0%)。多变量方法可以更好地同时覆盖截距和斜率效应的联合覆盖范围。我们还将我们的方法应用于两个帕金森病队列,以研究身体质量指数对疾病进展的影响。没有强有力的证据表明 BMI 会影响疾病进展,但是截距和斜率的置信区间都很宽。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c2/11219432/4b683a0218d7/10654_2023_1093_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c2/11219432/0f0b8d7ce80d/10654_2023_1093_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c2/11219432/4b683a0218d7/10654_2023_1093_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c2/11219432/0f0b8d7ce80d/10654_2023_1093_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8c2/11219432/4b683a0218d7/10654_2023_1093_Fig2_HTML.jpg

相似文献

1
Two sample Mendelian Randomisation using an outcome from a multilevel model of disease progression.两样本孟德尔随机化分析使用疾病进展多层次模型的结果。
Eur J Epidemiol. 2024 May;39(5):521-533. doi: 10.1007/s10654-023-01093-2. Epub 2024 Jan 28.
2
Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study.评估体重指数对帕金森病风险的因果影响:一项孟德尔随机化研究。
PLoS Med. 2017 Jun 13;14(6):e1002314. doi: 10.1371/journal.pmed.1002314. eCollection 2017 Jun.
3
Mendelian Randomisation Finds No Causal Association between Urate and Parkinson's Disease Progression.孟德尔随机化研究未发现尿酸与帕金森病进展之间存在因果关系。
Mov Disord. 2021 Sep;36(9):2182-2187. doi: 10.1002/mds.28662. Epub 2021 May 31.
4
The Parkinson's Disease Mendelian Randomization Research Portal.帕金森病孟德尔随机化研究门户。
Mov Disord. 2019 Dec;34(12):1864-1872. doi: 10.1002/mds.27873. Epub 2019 Oct 28.
5
Mendelian Randomization - the Key to Understanding Aspects of Parkinson's Disease Causation?孟德尔随机化——理解帕金森病病因的关键?
Mov Disord. 2016 Apr;31(4):478-83. doi: 10.1002/mds.26492. Epub 2015 Dec 23.
6
Using multivariable Mendelian randomization to estimate the causal effect of bone mineral density on osteoarthritis risk, independently of body mass index.采用多变量孟德尔随机化方法,独立于体重指数,估计骨密度对骨关节炎风险的因果效应。
Int J Epidemiol. 2022 Aug 10;51(4):1254-1267. doi: 10.1093/ije/dyab251.
7
Genetic causal role of body mass index in multiple neurological diseases.体重指数在多种神经疾病中的遗传因果作用。
Sci Rep. 2024 Mar 27;14(1):7256. doi: 10.1038/s41598-024-57260-2.
8
Evidence for genetic causality between iron homeostasis and Parkinson's disease: A two-sample Mendelian randomization study.铁稳态与帕金森病之间存在遗传因果关系的证据:一项两样本孟德尔随机化研究。
J Trace Elem Med Biol. 2024 Jul;84:127430. doi: 10.1016/j.jtemb.2024.127430. Epub 2024 Mar 11.
9
Association Between Neuroinflammation and Parkinson's Disease: A Comprehensive Mendelian Randomization Study.神经炎症与帕金森病的关联:一项综合的孟德尔随机化研究。
Mol Neurobiol. 2024 Dec;61(12):10216-10226. doi: 10.1007/s12035-024-04197-2. Epub 2024 May 6.
10
Non-linear Mendelian randomization: detection of biases using negative controls with a focus on BMI, Vitamin D and LDL cholesterol.非线性孟德尔随机化:使用阴性对照检测偏倚,重点关注 BMI、维生素 D 和 LDL 胆固醇。
Eur J Epidemiol. 2024 May;39(5):451-465. doi: 10.1007/s10654-024-01113-9. Epub 2024 May 25.

引用本文的文献

1
Cardiovascular diseases and depression: A meta-analysis and Mendelian randomization analysis.心血管疾病与抑郁症:一项荟萃分析和孟德尔随机化分析
Mol Psychiatry. 2025 Apr 17. doi: 10.1038/s41380-025-03003-2.

本文引用的文献

1
Two-stage multivariate Mendelian randomization on multiple outcomes with mixed distributions.两阶段多变量孟德尔随机化分析混合分布结局。
Stat Methods Med Res. 2023 Aug;32(8):1543-1558. doi: 10.1177/09622802231181220. Epub 2023 Jun 20.
2
Mendelian randomization.孟德尔随机化
Nat Rev Methods Primers. 2022 Feb 10;2. doi: 10.1038/s43586-021-00092-5.
3
Strategies to investigate and mitigate collider bias in genetic and Mendelian randomisation studies of disease progression.探讨和减轻疾病进展的遗传和孟德尔随机化研究中碰撞偏差的策略。
PLoS Genet. 2023 Feb 23;19(2):e1010596. doi: 10.1371/journal.pgen.1010596. eCollection 2023 Feb.
4
Average Causal Effect Estimation Via Instrumental Variables: the No Simultaneous Heterogeneity Assumption.通过工具变量估计平均因果效应:无同时期异质性假设
Epidemiology. 2023 May 1;34(3):325-332. doi: 10.1097/EDE.0000000000001596. Epub 2023 Jan 30.
5
Estimation of causal effects of a time-varying exposure at multiple time points through multivariable mendelian randomization.通过多变量孟德尔随机化估计多个时间点随时间变化的暴露因素的因果效应。
PLoS Genet. 2022 Jul 18;18(7):e1010290. doi: 10.1371/journal.pgen.1010290. eCollection 2022 Jul.
6
Interpretation of Mendelian randomization using a single measure of an exposure that varies over time.使用随时间变化的暴露因素的单一测量值来解释孟德尔随机化。
Int J Epidemiol. 2022 Dec 13;51(6):1899-1909. doi: 10.1093/ije/dyac136.
7
Adjusting for collider bias in genetic association studies using instrumental variable methods.利用工具变量法调整遗传关联研究中的混杂偏倚。
Genet Epidemiol. 2022 Jul;46(5-6):303-316. doi: 10.1002/gepi.22455. Epub 2022 May 18.
8
Using linear and natural cubic splines, SITAR, and latent trajectory models to characterise nonlinear longitudinal growth trajectories in cohort studies.使用线性和自然三次样条、SITAR 和潜在轨迹模型来描述队列研究中非线性纵向生长轨迹。
BMC Med Res Methodol. 2022 Mar 15;22(1):68. doi: 10.1186/s12874-022-01542-8.
9
A robust method for collider bias correction in conditional genome-wide association studies.一种稳健的条件全基因组关联研究中碰撞偏差校正方法。
Nat Commun. 2022 Feb 2;13(1):619. doi: 10.1038/s41467-022-28119-9.
10
High Level of Uromodulin Increases the Risk of Hypertension: A Mendelian Randomization Study.尿调节蛋白水平升高增加高血压风险:一项孟德尔随机化研究
Front Cardiovasc Med. 2021 Sep 1;8:736001. doi: 10.3389/fcvm.2021.736001. eCollection 2021.